{"title":"Farmaci per Prurito e Irritazioni della Pelle","description":"\u003cp\u003eCreme e gel per calmare il prurito e le irritazioni della pelle: idrocortisone a bassa potenza, antistaminici topici, anestetici locali e paste protettive allo zinco. Utili per dermatiti da contatto, arrossamenti, eritemi, punture di insetto e pelle sensibile. Spedizione veloce in 24\/48 ore.\u003c\/p\u003e","products":[{"product_id":"cortidro-0-5-crema-20g","title":"Cortidro 0.5% cream 20g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product is used in case of insect bites, itching, erythema or localized burns, eczema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of cream contains 0.5 g of Hydrocortisone acetate Excipients with known effects: cetostearyl alcohol, methyl p-hydroxybenzoate and propyl p-hydroxybenzoate For the complete list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCetostearyl alcohol, Sodium lauryl sulfate, Vaseline oil, Stringy Vaseline, methyl P-hydroxybenzoate, propyl P-hydroxybenzoate, Distilled water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. The use of hydrocortisone is contraindicated in the case of viral, bacterial or fungal diseases.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor adults and children over two years of age: apply a minimal amount of cream to the area and rub lightly to facilitate penetration. The application can be repeated two or three times a day for a few days. In case of failure to respond to therapy, it is advisable to contact your doctor. Do not exceed the recommended dose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe cream is not used in ophthalmology nor should it be applied to the areas around the eyes. Avoid use in the treatment of vulvar itching if associated with vaginal discharge. Avoid prolonged applications, particularly on large surfaces. The use, especially if prolonged, of topical products can give rise to irritation or sensitization phenomena. In this case it is necessary to interrupt treatment and consult your doctor in order to institute suitable therapy. \u003cu\u003eVisual disturbances\u003c\/u\u003e Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. \u003cu\u003ePediatric population\u003c\/u\u003e In children under two years of age, the product should be administered in cases of actual need under the direct supervision of a doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is necessary to observe caution in the association of corticosteroids with amphotericin B because they can combine their hypokalemic actions. Corticosteroids antagonize the effects of anticoagulants, therefore simultaneous use with them is not recommended, especially if they are coumarin derivatives. Barbiturates accelerate the metabolism of corticosteroids due to enzymatic induction and reduce their effect, therefore their combination is not recommended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSystemic side effects of corticosteroid preparations for topical use are extremely unlikely due to the low doses used: if they occur, discontinue therapy. Eye disorders, uncommon (≥1\/1,000, \u003c1\/100): Vision, blurred (see also section 4.4). \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt the indicated doses, no clinically unfavorable symptoms were detected; in case of emergency the doctor intervenes according to the symptoms detected.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product should be administered in cases of actual need and under the direct supervision of a doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCortidro does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131255718215,"sku":"010318032","price":14.79,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-cortidro-0-5-crema-20g-farmacia-dottor-tili-1213792280.jpg?v=1767143770"},{"product_id":"polaramine-1-crema-25g","title":"Polaramine 1% cream 25g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePolaramin 1% cream\u003c\/b\u003e It is indicated for the local symptomatic treatment of itchy dermatitis, sunburn and insect bites.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDeschlorpheniramine maleate 1 g \/ 100 g. Excipients: Cetyl alcohol; Lanolin ethoxylated esters; Methyl p-hydroxybenzoate. For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAllantoin, Glycerin, Sorbitol 70%, Glyceryl monostearate, Spermaceti, Cetyl alcohol, Ethoxylated lanolin esters, Methyl p-hydroxybenzoate, Liquid paraffin, Natural lavender essence, Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApply the cream to the affected part with a light massage to promote deep penetration, 2-3 times a day, depending on the intensity of the inflammatory symptom.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePolaramin 1% cream\u003c\/b\u003e It is not for ophthalmic use. \u003cb\u003ePolaramin 1% cream\u003c\/b\u003e it is well tolerated but its use, especially if prolonged, can give rise to sensitization phenomena, as with all topical products. In this case, suspend treatment and institute suitable therapy. Avoid application on very large areas in the presence of abrasions to avoid systemic absorption. If absorbed, it may cause excitability, especially in children. Do not apply on exuding surfaces, on live sores, on areas of skin with blisters, genital organs, mucous membranes. Exposure to the sun of the treated areas can give rise to photosensitization phenomena. Stop using \u003cb\u003ePolaramin 1% cream\u003c\/b\u003e if you experience a burning sensation or rash, or if the original condition persists or if irritation develops. Avoid occlusive dressing. The use of antihistamines should be stopped approximately 48 hours before carrying out skin tests as these medicines can prevent or reduce positive reactions. The medicine contains: - cetyl alcohol and ethoxylated esters of lanolin which can cause local skin reactions (e.g. contact dermatitis); - methyl parahydroxybenzoate which can cause allergic reactions (even delayed); - an aroma containing limonene and linalool. Limonene and linalool can cause allergic reactions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot known.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe local application of \u003cb\u003ePolaramin 1% cream\u003c\/b\u003e it can cause burning, skin rashes and photosensitivity reactions. After topical application of antihistamines on large areas of the skin, systemic side effects have been reported. Reporting of suspected adverse reactions Reporting of suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system, https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo date, there are no known cases of overdose due to the use of \u003cb\u003ePolaramin 1% cream\u003c\/b\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn pregnant and breastfeeding women, the product should only be used if clearly necessary and under the direct supervision of a doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":51131265548615,"sku":"018554081","price":11.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bayer-spa-polaramine-1-crema-25g-farmacia-dottor-tili-1213792281.jpg?v=1767144170"},{"product_id":"reactifargan-2-crema-20g","title":"Reactifargan 2% cream 20g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal symptomatic treatment for insect bites and other localized skin irritation phenomena such as redness, burning, itching and sunburn.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eActive ingredient: promethazine 2.00 g Excipients with known effects: methyl-para-hydroxybenzoate, propyl-para-hydroxybenzoate, D-limonene, geraniol, linalool and butylated hydroxytoluene. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePolyacrylamide isoparaffin laureth-7, octyl methoxycinnamate, methyl parahydroxybenzoate, propyl parahydroxybenzoate, lavender compound oil, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Eczema Secreting lesions. Children under 2 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Apply 3-4 times a day. Do not exceed the recommended number of daily applications. Avoid application on very large areas of the body. \u003cu\u003eMethod of administration\u003c\/u\u003e Topical use.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProlonged and inappropriate use of the product can give rise to allergic sensitization phenomena with consequent worsening of symptoms. If this occurs, treatment should be suspended and the situation reassessed. If applied to very large areas of the skin REACTIFARGAN may cause drowsiness (see section 4.7). Given that the application of REACTIFARGAN can delay the healing process, it must not be used more than 3-4 consecutive days on lesions in which this phenomenon is taking place. In the case of sunburn, apply the product and avoid further exposure of the irritated skin to the sun. If skin rashes, irritation and burning phenomena occur, treatment should be suspended. \u003cb\u003eImportant information about some excipients\u003c\/b\u003e REACTIFARGAN contains \u003cb\u003emethyl p-hydroxybenzoate\u003c\/b\u003e e \u003cb\u003epropyl p-hydroxybenzoate\u003c\/b\u003e which can cause allergic reactions (even delayed). REACTIFARGAN contains lavender oil, a fragrance which in turn contains D-Limonene, geraniol and linalool which can cause allergic reactions; REACTIFARGAN contains octyl methoxycinnamate which in turn contains butylated hydroxytoluene which may cause localized skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot known.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe side effects reported below arise from post-marketing and have an unknown frequency (the frequency cannot be established from the available data).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequency not known: Dermatitis edema erythema bullous lesions photosensitivity\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo clinical data are available regarding the risk during pregnancy and breastfeeding. The administration of REACTIFARGAN during pregnancy and breast-feeding should only be considered if the expected benefit for the mother outweighs the risk for the fetus or child.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eToo abundant application of the product on very large areas of the skin can determine the absorption of the drug and cause drowsiness in particularly sensitive patients. Instruct the patient to pay particular attention before driving or using machinery.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51131364933959,"sku":"002516060","price":13.06,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-reactifargan-2-crema-20g-farmacia-dottor-tili-1213791913.jpg?v=1767115768"},{"product_id":"fenistil-1-mg-ml-20-ml-gocce-orali-soluzione","title":"Fenistil 1 mg\/ml 20 ml oral drops solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Symptomatic treatment of itching of various origins. - Symptomatic treatment of drug and food allergies.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eFenistil oral drops, solution\u003c\/u\u003e 1 ml of solution contains dimethindene maleate 1 mg. Excipients with known effects: benzoic acid, propylene glycol, sodium. \u003cu\u003eFenistil coated tablets\u003c\/u\u003e Each coated tablet contains dimethindene maleate 1 mg. Excipients with known effects: lactose, sucrose, wheat starch. For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eFenistil oral drops\u003c\/u\u003e Disodium phosphate dodecahydrate; propylene glycol; benzoic acid; disodium edetate; citric acid monohydrate; sodium saccharin; purified water. \u003cu\u003eFenistil coated tablets\u003c\/u\u003e Lactose, wheat starch, magnesium stearate, talc, sucrose, calcium carbonate, gum arabic, titanium dioxide, macrogol.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Glaucoma, prostatic hypertrophy, obstructions of the bladder neck, pyloric, duodenal or other tracts of the gastrointestinal and urogenital tracts. Asthma and chronic obstructive pulmonary disease. Cardiovascular diseases and hypertension. Hyperthyroidism. Epilepsy. Concomitant treatment with monoamine oxidase inhibitors. Infants less than 1 month old, especially premature infants.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAdults and children over 12 years of age\u003c\/i\u003e The recommended daily dose is 3-6 mg of dimethindene maleate per day, divided into three administrations. This corresponds to the administration of: - 1 mg\/ml drops: 20-40 drops 3 times a day; - 1 mg coated tablets: 1-2 coated tablets 3 times a day. In patients who have a tendency to drowsiness, 2 coated tablets (or 40 drops) are prescribed in the evening, before going to bed and 1 coated tablet (or 20 drops) during breakfast. \u003ci\u003ePediatric population\u003c\/i\u003e \u003ci\u003e \u003cu\u003eChildren (under 12 years of age) \u003c\/u\u003e \u003c\/i\u003e\u003cb\u003e \u003ci\u003eIn children under 12 years of age, use the medicine only upon medical prescription.\u003c\/i\u003e \u003c\/b\u003e The recommended daily dose is 0.1 mg\/kg of body weight\/day, i.e. 2 drops per kg of body weight per day, divided into three daily administrations. 20 drops = 1 ml = 1 mg of dimethindene maleate. Fenistil drops must not be subjected to high temperatures: add the drops into the bottle at the last moment, when the contents are lukewarm. If the child is able to eat with a spoon, administer the drops undiluted in a teaspoon. Their flavor is pleasant. \u003ci\u003e \u003cu\u003eElderly\u003c\/u\u003e \u003c\/i\u003e The safety and efficacy of dimethindene in patients over 65 years of age have not been systematically evaluated. Use only for short treatment periods.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFenistil coated tablets: store in the original packaging. Fenistil oral drops: store below 25°C. Keep the bottle in the original package in order to protect the medicine from light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in patients with severe liver disease. Antihistamines can cause photosensitization: after administration of the medicine, avoid exposure to sunlight. Use with caution in the elderly as they are more subject to adverse reactions such as agitation and fatigue. Avoid use in elderly patients with mental confusion. \u003cu\u003ePediatric population\u003c\/u\u003e Particular attention should be paid when determining the dose in the pediatric population. In children under 12 years of age, use the medicine only upon medical prescription. Caution is recommended when administering any antihistamine to children under 1 year of age: the sedative effect may be associated with episodes of apnea during sleep. In younger children, it has been reported that antihistamines can induce excitability. \u003cu\u003eImportant information about some excipients:\u003c\/u\u003e Fenistil tablets contains: - \u003cb\u003elactose\u003c\/b\u003e: Patients suffering from rare hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine. - \u003cb\u003eSucrose\u003c\/b\u003e: Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. - \u003cb\u003eWheat starch\u003c\/b\u003e: in this medicine, wheat starch contains only a very small amount of gluten; it is very unlikely that it could cause problems in case of celiac disease. One tablet contains no more than 0.2 micrograms of gluten. People with a wheat allergy (condition other than celiac disease) should not take this medicine. Fenistil oral drops contains: - \u003cb\u003ebenzoic acid: \u003c\/b\u003eThis medicine contains 2 mg of benzoic acid per dose (40 drops) equivalent to 1 mg\/ml. - \u003cb\u003ePropylene glycol: \u003c\/b\u003eThis medicine contains 200 mg of propylene glycol per dose (40 drops) equivalent to 100 mg\/ml. Clinical monitoring is required for patients with hepatic or renal insufficiency due to various adverse events attributed to propylene glycol such as renal dysfunction (acute tubular necrosis), acute kidney injury, and hepatic dysfunction. - \u003cb\u003eSodium: \u003c\/b\u003eThis medicine contains less than 1 mmol (23 mg) sodium per dose (equivalent to 40 drops), i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe effect on the central nervous system of central nervous system depressant drugs (such as tranquilizers, opioid analgesics, anticonvulsants, antihistamines, antiemetics, antipsychotics, anxiolytics, hypnotics, scopolamine and alcohol) may be strengthened by dimethindene maleate. This can cause undesirable consequences that could be life-threatening. Tricyclic antidepressants and anticholinergics (e.g. bronchodilators, gastrointestinal antispasmodics, mydriatics, urological antimuscarinics) may exert an additive antimuscarinic effect with that of antihistamines, increasing the risk of worsening glaucoma or urinary retention. To minimize CNS depression and possible potentiation, coadministration of procarbazine and antihistamines should be used with caution. The use of antihistamines can mask the first signs of ototoxicity of some antibiotics and can reduce the duration of action of oral anticoagulants.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eSafety profile summary\u003c\/u\u003e \u003c\/b\u003e Side effects include drowsiness, especially at the beginning of treatment. In very rare cases, allergic reactions may occur. \u003cb\u003e \u003cu\u003eTable of adverse reactions\u003c\/u\u003e \u003c\/b\u003e Side effects are listed below by system organ class and frequency. Frequencies are defined as: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000), or not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are reported in order of decreasing seriousness.\u003c\/p\u003e\n\u003cp\u003eFrequency - Adverse event: Adverse event.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Skin rashes, Photosensitization, Anaphylactoid reactions (including facial edema, pharyngeal edema and dyspnoea).\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse event: Agitation.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Signs of excitement (such as euphoria, tremor, insomnia, convulsions).\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eVery common - Adverse event: Fatigue\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse event: Drowsiness, Nervousness.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse event: Headache, Dizziness.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Sedation.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Asthenia.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Coordination disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Vision disturbances.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal pathologies.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Dryness of the nose, Reduction and thickening of bronchial secretion accompanied by a sense of chest tightness and breathing difficulty.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eRare - Adverse event: Gastrointestinal disorders, Nausea, Dry mouth and throat.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Anorexia, Vomiting, Diarrhea or constipation.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse event: Difficulty in urination, Urinary retention.\u003c\/p\u003e\n\u003cp\u003eYou can also check: \u003cu\u003eSkin and subcutaneous tissue disorders:\u003c\/u\u003e Isolated cases of edema, skin rash. \u003cu\u003eMusculoskeletal system and connective tissue disorders:\u003c\/u\u003e Muscle spasm. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e In case of overdose, as with other antihistamines H\u003csub\u003e1\u003c\/sub\u003e the following symptoms may occur: central nervous system depression with drowsiness (especially in adults), central nervous system stimulation and anticholinergic effects (especially in children and the elderly) with excitation, ataxia, hallucinations, tremors, convulsions, tonic-clonic spasms, mydriasis, dry mouth, facial flushing, urinary retention and fever. Furthermore, hypotension, worsening coma with cardiorespiratory collapse and death may appear. No fatal outcome has been reported following overdose of Fenistil. \u003cb\u003eManagement\u003c\/b\u003e There is no specific antidote in case of overdose of antihistamines; the usual emergency measures must be implemented: induction of vomiting, gastric lavage if vomiting has not been induced, administration of activated charcoal, saline laxatives and the usual cardio-respiratory support measures. Do not administer stimulants; Vasopressor drugs may be used to treat hypotension.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy\u003c\/b\u003e No clinical data on pregnancy are available for dimethindene maleate. Animal studies have not shown direct or indirect harmful effects on pregnancy or the fetus\/newborn. The safety of use during pregnancy has not been evaluated in humans. Fenistil should be administered during pregnancy only after the doctor has assessed the risk\/benefit ratio by estimating that the benefit for the mother outweighs the risk for the fetus. \u003cb\u003eBreastfeeding\u003c\/b\u003e The use of Fenistil is not recommended during breastfeeding as the excretion of dimethindene maleate in breast milk cannot be excluded. \u003cb\u003eFertility\u003c\/b\u003e No effects on fertility were observed in animal studies.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt common therapeutic doses the most frequent side effect is sedation which can cause drowsiness; Those who drive motor vehicles or who carry out operations that require an intact level of supervision must be warned of this.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51730204918087,"sku":"020124020","price":10.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-fenistil-1-mg-ml-20-ml-gocce-orali-soluzione-farmacia-dottor-tili-1213791390.jpg?v=1767139269"},{"product_id":"ortodermina-5-50-g-crema","title":"Ortodermina 5% 50 g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAnesthetic of the accessible mucous membranes of the oro-pharyngeal cavity, anorectal itching. Anesthetic in case of minor skin lesions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of cream contains 6.15 g of Lidocaine hydrochloride, equal to 5 g Lidocaine base. Excipients with known effects: cetostearyl alcohol\u003cb\u003e,\u003c\/b\u003e Methyl p-hydroxybenzoate. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCetostearyl alcohol, Macrogol cetostearyl ether, Vaseline oil, White stringy Vaseline, Methyl p-hydroxybenzoate, Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApply the cream on the injured part appropriately; if the skin shows lacerations, it is recommended to spread the cream using a sterile gauze pad. In dentistry, during anesthesia of the mucosa of the oral cavity, dry the latter with a cotton ball and with a saliva ejector in order to minimize the dilution of the cream and promote maximum absorption of the lidocaine. When fitting a new denture, spread the cream on the surface in contact with the mucosa (Important: the settling-in period). In case of anal-rectal itching, to facilitate administration, it is possible to use the applicator cannula (included in the 3 g package). Daily application must not exceed 35 g of cream.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eORTODERMINA must be used with caution by those subjects who have particularly traumatized mucosa and sepsis in the region intended for application of the cream. In any case, the safety of use depends on the dosage, correct application technique and the adoption of precautionary measures. The product should be used at the minimum effective dose, appropriately reducing the dose in relation to age and physical condition in children, the elderly and acutely ill patients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known interactions with other substances.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal and general allergic reactions up to anaphylactoid manifestations may occur with the use of lidocaine. The appearance of systemic signs is rare and is due to excessive dosage, rapid absorption, hypersensitivity or reduced tolerance. In these cases, cardiovascular depression and nervous excitation may occur followed by sedation with drowsiness or loss of consciousness. In such cases it is necessary to take appropriate emergency measures. \u003cb\u003eReporting of suspected adverse reactions.\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive dosage, rapid absorption and hypersensitivity or reduced tolerance cause the appearance of cardiovascular depression and nervous excitation followed by sedation with drowsiness or loss of consciousness. In such cases it is necessary to take appropriate emergency measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn pregnant women and in early childhood, the product must be used only in case of actual need and under direct medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51730208293191,"sku":"005556016","price":15.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-ortodermina-5-50-g-crema-farmacia-dottor-tili-1213791078.jpg?v=1767154290"},{"product_id":"sintotrat-0-5-20-g-crema","title":"Sintotrat 0.5% 20 g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSintotrat 0.5% cream is indicated for the symptomatic treatment of itching, eczema, insect bites, erythema or localized burns.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of cream contains: \u003cstrong\u003eActive ingredient\u003c\/strong\u003e: Hydrocortisone acetate 0.5 g.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePolyglycolic esters of fatty acids, Silicone oil 350 cP, Propylene glycol, Glycerin, Methyl p-hydroxybenzoate, Propyl p-hydroxybenzoate, Ethylenediaminetetraacetic acid, Purified water.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndividual hypersensitivity confirmed towards the product. As with any other cortisone preparation for topical use, the use of Sintotrat 0.5% cream is contraindicated in the case of viral, bacterial and fungal diseases.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not exceed the recommended doses. If the symptoms do not resolve within a few days, treatment should be discontinued and a doctor should be consulted.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNone\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSintotrat 0.5% cream is indicated for external use only. The cream is not used ophthalmologically, but should be applied to the areas around the eyes. Avoid prolonged applications, particularly on large surfaces. Not to be used in the treatment of vulvar itching if associated with vaginal discharge. \u003cstrong\u003eVisual disturbances\u003c\/strong\u003e Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. In children under two years of age, the product should be administered in cases of real need under the direct supervision of a doctor. Keep the medicine out of the reach of children. Do not use the medicine beyond the expiry date indicated on the package.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo negative interactions or incompatibilities of use with other drugs commonly used in the relevant therapy have ever been identified.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of products for topical use can give rise to local irritation or sensitization phenomena; in this case it is necessary to interrupt the treatment and consult the doctor in order to institute suitable therapy. Systemic side effects of corticosteroid preparations for topical use are extremely unlikely due to the low doses used; in case of onset it is necessary to interrupt therapy and consult your doctor or pharmacist Classification of expected frequencies: very common (≥1\/10), common (≥1\/100, ≤1\/10), uncommon (≥1\/1000, \u003c1\/100), rare (≥1\/10000, \u003c1\/1000), very rare (\u003c1\/10000), not known (the frequency cannot be defined on the basis of available data). The following adverse reactions have been observed with topical corticosteroids: Eye disorders. Not known: Blurred vision (see also section 4.4). \u003cstrong\u003eReporting of suspected adverse reactions\u003c\/strong\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCases of overdose are not known with the topical use of hydrocortisone at the concentration contained in Sintotrat 0.5% cream; however, avoid prolonged applications, particularly on large surfaces.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn pregnant women, the product should be administered in cases of actual need under the direct supervision of a doctor.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product does not affect the ability to drive and use machines.\u003c\/p\u003e","brand":"Dompé","offers":[{"title":"Default Title","offer_id":51730209964359,"sku":"025753017","price":11.16,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dompe-farmaceutici-spa-sintotrat-0-5-20-g-crema-farmacia-dottor-tili-1213791060.jpg?v=1767154649"},{"product_id":"lenirit-0-5-20-g-crema","title":"Lenirit 0.5% 20 g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eInsect bites, itching, localized erythema or burns, eczema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of cream contains: \u003cu\u003eActive ingredient\u003c\/u\u003e: hydrocortisone acetate 0.5 g. \u003cu\u003eExcipients with known effects\u003c\/u\u003e: methyl parahydroxybenzoate; ethyl parahydroxybenzoate; propyl parahydroxybenzoate. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePolyglycolic ester of C12-C18 fatty acids; self-emulsifying glyceryl monodistearate; squalane; cetyl palmitate; methyl parahydroxybenzoate; ethyl parahydroxybenzoate; propyl parahydroxybenzoate; perfume; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKnown hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Infections and skin diseases: tuberculosis, pyoderma, mycosis, as well as skin ulcers and wounds, skin tumors. The use of the cream is contraindicated on the skin of the face, on the anogenital area, on large lesions, infectious diseases (syphilis), viral infectious diseases (such as herpes, chickenpox), perioral dermatitis, acne, acne rosacea, skin reactions after a vaccination, pustular psoriasis. Lenirit should not be used in infants and children under 2 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRubbing lightly, spread the cream on the affected part in a thin layer, twice a day. Do not exceed the recommended doses. LENIRIT must not be used in children under two years of age (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIf conditions worsen or if symptoms persist for more than 7 days, discontinue applications and consult a doctor. Avoid contact with eyes. The use, especially if prolonged, of topical medicines can give rise to irritation or sensitization phenomena. In this case it is necessary to interrupt treatment and institute appropriate therapy. Prolonged use of this medicine may cause telangiectasia and skin atrophy. When used for a long period, or on a large area of ​​skin, hydrocortisone can be absorbed into the blood and exert systemic activity. This eventuality occurs more easily if occlusive dressing is used; the diaper can act as an occlusive bandage. Systemic absorption of topical corticosteroids may result in reversible suppression of the hypothalamic-pituitary-adrenal axis with potential glucocorticosteroid failure after treatment discontinuation. Following the systemic absorption of topical corticosteroids, some patients may also experience manifestations of Cushing's syndrome, glycosuria, hyperglycemia during treatment. Patients who apply a topical steroid to a large surface area or to occlusive areas should be monitored periodically for hypothalamic-pituitary-adrenal axis suppression. Visual disturbances: Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. In case of use in the area adjacent to the eyes, appropriate precautions should be taken. If this happens, the cream residue must be rinsed off with water. The cream contains ethyl parahydroxybenzoate, methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (even delayed). \u003ci\u003ePediatric population\u003c\/i\u003e: Do not use in infants and children under 2 years of age (see section 4.3). Particular caution is recommended when using the medicine in children due to the risk of systemic exposure to hydrocortisone. Because the body surface area to body weight ratio in children is higher than that in adults, children are at greater risk for systemic corticosteroid effects, including hypothalamic-pituitary-adrenal axis suppression and Cushing's syndrome, than adults. Prolonged use of corticosteroids in children can cause growth and development disorders. The duration of treatment should be as short as possible and the lowest dose should be used. The growth and development of the child should be monitored (see section 4.4). \u003ci\u003eUse in elderly patients\u003c\/i\u003e: Elderly people may experience more marked side effects, especially in cases of co-morbidities, such as osteoporosis, hypertension, hypokalemia, diabetes mellitus, in addition to greater susceptibility to infections and reduction in skin thickness. These people must be carefully monitored to avoid the appearance of life-threatening reactions. In case of subcutaneous atrophic conditions, especially in the elderly, the medicine should be used with caution. \u003ci\u003eUse in patients with renal or hepatic impairment\u003c\/i\u003e: Particular precautions for use must be used in patients with liver disease or renal failure and frequent clinical monitoring of the state of health is necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of interaction and incompatibility with other medicinal products have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of products for topical use can give rise to irritation or sensitization phenomena. In this case it is necessary to interrupt treatment and institute appropriate therapy. Acne, steroid-induced purpura, dry skin, hypertrichosis, hypopigmentation of the skin, skin atrophy and striae, telangiectasia, perioral dermatitis, folliculitis, pruritus, blurred vision may occur during application of the cream (see also section 4.4). The greater absorption due to the use of an occlusive bandage can cause systemic effects such as edema, hypertension and compromise of the immune system; suppression of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome may also occur, particularly in pediatric patients. Prolonged use of corticosteroids in children may cause growth and development disorders (see section 4.4). Glaucoma or cataracts may occasionally occur following topical application in the eyelid area (see section 4.4). \u003ci\u003eThe incidence of adverse reactions is not known.\u003c\/i\u003e \u003cb\u003e \u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCases of overdose are not known with the topical use of hydrocortisone at the concentration contained in LENIRIT (0.5%), however prolonged applications should be avoided, particularly on large surfaces. If high doses of the medicinal product are used on large areas of skin, under tight-fitting clothing or on damaged skin, the medicinal product may be absorbed into the blood and cause systemic corticosteroid effects (see section 4.4). In this case, a gradual discontinuation of treatment is recommended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of Lenirit is not recommended during pregnancy and breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Eg","offers":[{"title":"Default Title","offer_id":51730209997127,"sku":"025869013","price":12.09,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/eg-spa-lenirit-0-5-20-g-crema-farmacia-dottor-tili-1213791059.jpg?v=1767154630"},{"product_id":"foille-insetti-0-5-15-g-crema","title":"Foille Insetti 0.5% 15 g cream","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eInsect bites, itching, rashes and eczema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of cream contains: \u003cu\u003eActive ingredient\u003c\/u\u003e: hydrocortisone 0.5 g \u003cu\u003eExcipients with known effects\u003c\/u\u003e: cetyl alcohol, stearyl alcohol, lanolin. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIsopropyl alcohol, cetyl alcohol, stearyl alcohol, lanolin, macrogol 1000 stearate, macrogol 4000 stearate, macrogol 6000 stearate, bitter almond flavoring and purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. The use of hydrocortisone is contraindicated in the case of viral, bacterial and fungal diseases.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRubbing lightly, spread the cream on the affected area in a thin layer, twice a day. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFOILLE INSETTI must be used only for external use. Do not apply on mucous membranes. Avoid contact with eyes. In children under 2 years of age FOILLE INSETTI must be used only after consulting the doctor and having evaluated with him the risk\/benefit ratio in your case. It is good practice to avoid prolonged use of INSECT FOILS, particularly on large surfaces. The use, especially if prolonged, of products for topical use can give rise to irritation or sensitization phenomena. In this case, it is necessary to stop treatment and consult your doctor in order to institute suitable therapy. If skin irritation appears, treatment must be suspended. After a short period of treatment without appreciable results, consult your doctor. Cases of pheochromocytoma crises, which can be fatal, have occurred after administration of corticosteroids. Corticosteroids should be administered to patients with suspected or proven pheochromocytoma only after an adequate risk\/benefit assessment. \u003cb\u003eVisual disturbances \u003c\/b\u003e Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. Foille Insetti contains cetyl alcohol, stearyl alcohol and lanolin which may cause local skin reactions (e.g. contact dermatitis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo notes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAs with all preparations for topical use, local sensitization reactions may occur. Generally speaking, topical application of corticosteroids does not lead to clinical evidence of systemic absorption. When applied to large surfaces, or for prolonged periods of time, or to non-intact skin, or in the case of occlusive dressings, hydrocortisone can be absorbed in quantities sufficient to cause systemic effects. \u003cb\u003e \u003cu\u003eSide effects due to Corticosteroids\u003c\/u\u003e \u003c\/b\u003e The frequency of undesirable effects is classified as follows: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥ 1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000) and not known (frequency cannot be estimated from the available data). \u003cb\u003eEndocrine disorders\u003c\/b\u003e Not known: pheochromocytoma crisis (see section 4.4). \u003cb\u003ePathologies of the skin and subcutaneous tissue\u003c\/b\u003e Not known: urticaria. \u003cb\u003eEye pathologies\u003c\/b\u003e Not known: blurred vision, central serous chorioretinopathy (CSCR), (see section 4.4). \u003cb\u003eReporting of suspected adverse reactions \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.agenziafarmaco.gov.it\/content\/comesegnalare-una-sospetti-reazione-avversa.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known symptoms that refer to overdose of the drug.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTo be used under the direct supervision of a doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFoille Insetti does not influence the state of vigilance; therefore it does not alter the ability to drive vehicles and use machinery.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":51730211340615,"sku":"020051037","price":10.83,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-manufacturing-b-v-foille-insetti-0-5-15-g-crema-farmacia-dottor-tili-1213791029.jpg?v=1767164649"},{"product_id":"zinco-ossido-marco-viti-10-30-g-unguento","title":"Zinc oxide Marco Viti 10% 30 g ointment","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSoothing and protective treatment of eczema, dermatosis and minor abrasions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of ointment contain Active ingredient: zinc oxide 10.0 g. For full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWhite Vaseline, liquid paraffin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApply the ointment locally, 1 or 2 times a day, on appropriately washed and dried skin. Due to its astringent and decongestant action it can also be used on irritated skin (for example diaper rash). Apply a layer of ointment to cover the affected area (especially when used to treat diaper rash); in case of burns and non-infected skin lesions, it is preferable to apply a thin layer of ointment, using a bandage if necessary. Perform a light circular massage on the affected area, so as to obtain partial absorption of the ointment, following which an opaque white residue remains.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original container protected from light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine must be used for external use only; may be harmful if ingested (see paragraph 4.9). Avoid contact of the drug with the eyes; in case of accidental contact, wash thoroughly with water. Do not use the medicine in case of burns or potentially infected wounds. If the ointment is used for diaper rash, watch for the rash to improve within a few days; otherwise, you need to resort to a different treatment. The use, especially if prolonged, of medicines for local use can give rise to irritation or sensitization phenomena. In this case, it is necessary to interrupt treatment and institute appropriate therapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo notes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of zinc oxide organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eImmune system disorders\u003c\/i\u003e Allergic\/hypersensitivity reaction: rash, hives, itching and\/or swelling (especially of the face, tongue, throat, lips), tightness in the chest, difficulty breathing.\u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Skin irritation. Burning, tingling and dark spots on the skin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. The poor percutaneous absorption of the drug makes the occurrence of symptoms and signs of overdose unlikely. In case of accidental ingestion, the following symptoms may be seen: diarrhoea, nausea and vomiting, hypoglycaemia, confusion, fatigue, lethargy, bleeding, jaundice, dark urine, cough, chills and fever, oral cavity irritation, kidney problems, copper deficiency.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGenerally, the use of the ointment during pregnancy and breastfeeding is considered safe if applied to limited areas and for short periods of time. \u003ci\u003ePregnancy\u003c\/i\u003e For zinc oxide ointment no clinical data on exposed pregnancies are available. This medicine, if used in accordance with the instructions for use, is not absorbed and therefore does not cause systemic effects; in case of damaged skin, it can be absorbed in minimal quantities. \u003ci\u003eBreastfeeding\u003c\/i\u003e There are no data available on the use of the medicine during breastfeeding and it is not known whether this active ingredient passes into breast milk. However, since the absorption of the drug can be considered negligible, it is very unlikely that significant quantities reach the breast milk.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51730213503303,"sku":"030360010","price":5.39,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-zinco-ossido-marco-viti-10-30-g-unguento-farmacia-dottor-tili-1213791000.jpg?v=1767156027"},{"product_id":"fenistil-0-1-30-g-gel","title":"Fenistil 0.1% 30 g gel","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLocal symptomatic treatment of itchy dermatitis, solar erythema, insect bites.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne gram of gel contains dimethindene maleate 1 mg Excipients with known effects: propylene glycol, benzalkonium chloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzalkonium chloride; sodium edetate; carbomer; sodium hydroxide; propylene glycol; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Do not use with occlusive dressings.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eApply the gel on the affected part with a light massage, to favor its deep penetration, 2-3 times a day, depending on the intensity of the inflammatory symptom. Do not exceed the recommended doses. Use only for short periods of time (no longer than 5-7 days).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use, especially if prolonged, of products for topical use can give rise to sensitization phenomena; if this occurs, treatment should be suspended and appropriate therapy instituted. Avoid applying the product when the skin has very extensive abrasions, to avoid systemic absorption of the product; also do not apply it on areas of skin with blisters, on live sores or on exuding surfaces. Avoid contact of the preparation with the eyes and prolonged exposure to the sun of the treated areas. \u003cu\u003ePediatric population\u003c\/u\u003e In children under 2 years of age, the use of the preparation on large skin surfaces, particularly on abraded and inflamed areas, should be avoided. \u003cu\u003eInformation on excipients\u003c\/u\u003e Fenistil gel contains 300 mg of propylene glycol per dose (2 g of gel) equivalent to 150 mg\/g of gel which may cause skin irritation. Fenistil gel also contains 0.1 mg of benzalkonium chloride per dose (2 g of gel) equivalent to 0.05 mg\/g of gel which may irritate the skin. If you are breastfeeding, do not apply this medicine to your breasts because your baby may ingest it with his milk.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed; however, the absorption of the active ingredient contained in Fenistil 0.1% gel in the body is very low and therefore interactions are very unlikely.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSafety profile summary\u003c\/b\u003e The most commonly reported adverse reactions during treatment are mild and transient skin reactions at the application site. \u003cb\u003eTable of adverse reactions\u003c\/b\u003e Adverse reactions are listed below, by system organ class and frequency. Within each frequency class, undesirable effects are presented in order of decreasing seriousness. Frequency categories for each adverse reaction include: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003ci\u003e \u003cu\u003ePathologies of the skin and subcutaneous tissue.\u003c\/u\u003e \u003c\/i\u003eUncommon: dry skin, burning sensation on the skin; Very rare (based on post-marketing reports): allergic dermatitis; Frequency not known: allergic skin reactions. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e So far, no case of overdose with Fenistil gel has been reported. However, accidental ingestion of considerable quantities of Fenistil gel may induce some symptoms characteristic of overdose with type H antihistamines\u003csub\u003e1\u003c\/sub\u003e: CNS depression with drowsiness (especially in adults), CNS stimulation and anticholinergic effects (especially in children and the elderly), including excitement, ataxia, hallucinations, tonic-clonic spasms, mydriasis, dry mouth, facial flushing, urinary retention and fever. Hypotension may also occur. \u003cb\u003eManagement\u003c\/b\u003e There is no specific antidote in case of overdose of antihistamines. The usual emergency measures must be implemented which include, in case of ingestion: activated charcoal, saline laxatives and, if necessary, the usual cardiorespiratory support measures. No stimulants should be administered; vasopressor drugs may be used to treat hypotension.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy\u003c\/b\u003e No clinical data on pregnancy are available for dimethindene maleate. Animal studies have not shown any direct or indirect harmful effects on pregnancy or the fetus\/newborn. Fenistil gel should be used during pregnancy only after the doctor has assessed the risk\/benefit ratio in favor of the latter. During pregnancy, Fenistil gel should not be applied to large skin surfaces, especially if abraded or inflamed. \u003cb\u003eBreastfeeding\u003c\/b\u003e Fenistil gel should be used during breastfeeding only after the doctor has assessed the risk\/benefit ratio in favor of the latter. During breastfeeding, Fenistil gel should not be applied to large skin surfaces, especially if abraded or inflamed. However, the product should not be applied to the breasts during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFenistil gel has no or negligible influence on the ability to drive and use machinery.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51730213667143,"sku":"020124121","price":11.64,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-fenistil-0-1-30-g-gel-farmacia-dottor-tili-1213790996.jpg?v=1767156069"}],"url":"https:\/\/www.dottortili.com\/en\/collections\/farmaci-per-prurito-e-irritazioni-della-pelle.oembed","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}